Connor, Clark & Lunn Investment Management (CC&L)
XBIT icon

Connor, Clark & Lunn Investment Management (CC&L)’s XBiotech XBIT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.4K Sell
28,663
-1,566
-5% -$3.79K ﹤0.01% 1512
2025
Q4 		$72.2K Sell
30,229
-5,800
-16% -$14.3K ﹤0.01% 1493
2025
Q3 		$95.8K Sell
36,029
-12,245
-25% -$36.3K ﹤0.01% 1458
2025
Q2 		$143K Sell
48,274
-16,911
-26% -$49.2K ﹤0.01% 1441
2025
Q1 		$211K Sell
65,185
-9,009
-12% -$31.1K ﹤0.01% 1324
2024
Q4 		$293K Sell
74,194
-1,521
-2% -$10.4K ﹤0.01% 1263
2024
Q3 		$585K Sell
75,715
-2,008
-3% -$13.2K ﹤0.01% 1057
2024
Q2 		$399K Buy
77,723
+310
+0.4% +$2.39K ﹤0.01% 1109
2024
Q1 		$629K Buy
77,413
+13,468
+21% +$77.2K ﹤0.01% 1040
2023
Q4 		$256K Sell
63,945
-373
-0.6% -$1.49K ﹤0.01% 1210
2023
Q3 		$265K Buy
64,318
+24
+0% +$120 ﹤0.01% 1174
2023
Q2 		$382K Buy
64,294
+6,378
+11% +$28.8K ﹤0.01% 1050
2023
Q1 		$200K Sell
57,916
-7,110
-11% -$26.5K ﹤0.01% 1100
2022
Q4 		$228K Sell
65,026
-2,949
-4% -$10.1K ﹤0.01% 1033
2022
Q3 		$246K Buy
67,975
+18,863
+38% +$88.8K ﹤0.01% 959
2022
Q2 		$277K Buy
49,112
+25,509
+108% +$172K ﹤0.01% 878
2022
Q1 		$204K Buy
+23,603
New +$237K ﹤0.01% 942

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s XBIT Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its XBiotech (XBIT) stake by 5.2% in Q1 2026, selling an estimated $3.79K and leaving 28,663 shares worth $67.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1512.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in XBIT in Q1 2022 and has held it in 17 quarters since. The position peaked at $629K in Q1 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 28,663 shares of XBiotech worth $67.4K as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,566 XBiotech shares in Q1 2026, an estimated $3.79K.
  • XBiotech made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1512 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in XBiotech in Q1 2022 and has held it in 17 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s XBiotech position peaked at $629K in Q1 2024.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.